Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Miyazaki, Y."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 40
Tytuł:
Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: summary of three phase I studies.
Autorzy:
Platzbecker U; Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Johannisallee 32, D-04103, Leipzig, Germany. .
Chromik J; Department of Hematology and Medical Oncology, University Hospital Frankfurt, Frankfurt, Germany.
Krönke J; Department of Internal Medicine, University Hospital of Ulm, Ulm, Germany.
Handa H; Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Strickland S; Division of Hematology and Oncology, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
Miyazaki Y; Department of Hematology, Nagasaki University Hospital, Nagasaki City, Japan.
Wermke M; NCT/UCC Early Clinical Trial Unit, Technical University Dresden, University Hospital Carl Gustav Carus, Dresden, Germany.
Sakamoto W; Biostatistics and Data Science Japan, Medical Division, Nippon Boehringer Ingelheim, Tokyo, Japan.
Tachibana Y; Clinical Operations Japan, Nippon Boehringer Ingelheim, Tokyo, Japan.
Taube T; Therapeutic Area Oncology Medicine, Boehringer Ingelheim International, Biberach, Germany.
Germing U; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Dusseldorf, Germany.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 May 21; Vol. 22 (1), pp. 569. Date of Electronic Publication: 2022 May 21.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myelomonocytic, Chronic*/chemically induced
Leukemia, Myelomonocytic, Chronic*/drug therapy
Myelodysplastic Syndromes*/chemically induced
Myelodysplastic Syndromes*/drug therapy
Thrombocytopenia*/chemically induced
Adult ; Azacitidine/therapeutic use ; Clinical Trials, Phase I as Topic ; Humans ; Pteridines
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Nationwide epidemiological survey of familial myelodysplastic syndromes/acute myeloid leukemia in Japan: a multicenter retrospective study.
Autorzy:
Takaoka K; Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Koya J; Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yoshimi A; Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Toya T; Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kobayashi T; Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Nannya Y; Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Nakazaki K; Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Arai S; Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Ueno H; Department of Hematology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
Usuki K; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
Yamashita T; Department of Internal Medicine, Keiju Kanazawa Hospital, Ishikawa, Japan.
Imanishi D; Department of Internal medicine, Nagasaki Goto Chuoh Hospital, Nagasaki, Japan.
Sato S; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
Harada H; School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Manabe A; Department of Pediatrics, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan.
Hayashi Y; Institute of Physiology and Medicine, Jobu University, Gunma, Japan.
Miyazaki Y; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
Kurokawa M; Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Department of Cell Therapy and Transplantation, The University of Tokyo Hospital, Tokyo, Japan.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2020 Jul; Vol. 61 (7), pp. 1688-1694. Date of Electronic Publication: 2020 Mar 11.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/epidemiology
Leukemia, Myeloid, Acute*/genetics
Myelodysplastic Syndromes*/diagnosis
Myelodysplastic Syndromes*/epidemiology
Myelodysplastic Syndromes*/genetics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Humans ; Japan/epidemiology ; Middle Aged ; Retrospective Studies ; Surveys and Questionnaires ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM).
Autorzy:
Della Porta MG; 1] Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy [2] Department of Internal Medicine, University of Pavia, Pavia, Italy.
Tuechler H; Hanusch Hospital, Boltzmann Institute for Leukemia Research, Vienna, Austria.
Malcovati L; 1] Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy [2] Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Schanz J; Georg August Universität, Göttingen, Germany.
Sanz G; Hospital Universitario La Fe, Valencia, Spain.
Garcia-Manero G; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
Solé F; Institut de Recerca contra la Leucèmia Josep Carreras, Barcelona, Spain.
Bennett JM; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Bowen D; St James's University Hospital, Leeds, UK.
Fenaux P; Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris (AP-HP)/University Paris XIII, Bobigny, France.
Dreyfus F; Hôpital Cochin, AP-HP University of Paris V, Paris, France.
Kantarjian H; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
Kuendgen A; Heinrich-Heine University Hospital, Düsseldorf, Germany.
Levis A; Fondazione Italiana Sindromi Mielodisplastiche c/o SS Antonio e Biagio Hospital, Alessandria, Italy.
Cermak J; Institute of Hematology and Blood Transfusion, Praha, Czech Republic.
Fonatsch C; Medical University of Vienna, Vienna, Austria.
Le Beau MM; University of Chicago Comprehensive Cancer Research Center, Chicago, IL, USA.
Slovak ML; Quest Diagnostics Nichols Institute, Chantilly, VA, USA.
Krieger O; Elisabethinen Hospital, Linz, Austria.
Luebbert M; University of Freiburg Medical Center, Freiburg, Germany.
Maciejewski J; Cleveland Clinic, Cleveland, OH, USA.
Magalhaes SM; Federal University of Ceara, Fortaleza, Brazil.
Miyazaki Y; Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Pfeilstöcker M; Hanusch Hospital and L. Boltzmann Cluster Oncology, Vienna, Austria.
Sekeres MA; Cleveland Clinic, Cleveland, OH, USA.
Sperr WR; Medical University of Vienna, Vienna, Austria.
Stauder R; Hanusch Hospital and L. Boltzmann Cluster Oncology, Vienna, Austria.
Tauro S; University of Dundee, Dundee, Scotland, UK.
Valent P; Medical University of Vienna, Vienna, Austria.
Vallespi T; Hospital Universitario Vall d'Hebron, Barcelona, Spain.
van de Loosdrecht AA; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
Germing U; Heinrich-Heine University Hospital, Düsseldorf, Germany.
Haase D; Georg August Universität, Göttingen, Germany.
Greenberg PL; Division of Hematology, Stanford University Cancer Center, Stanford, CA, USA.
Cazzola M; 1] Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy [2] Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2015 Jul; Vol. 29 (7), pp. 1502-13. Date of Electronic Publication: 2015 Feb 27.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms:
World Health Organization*
Myelodysplastic Syndromes/*classification
Myelodysplastic Syndromes/*diagnosis
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Combined Modality Therapy ; Cytogenetic Analysis ; Female ; Follow-Up Studies ; Humans ; International Cooperation ; Male ; Middle Aged ; Myelodysplastic Syndromes/mortality ; Myelodysplastic Syndromes/therapy ; Neoplasm Staging ; Prognosis ; Research Design ; Risk Assessment ; Survival Rate ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.
Autorzy:
Ueda Y; Department of Hematology/Oncology, Transfusion and Hemapheresis Center, Kurashiki Central Hospital, Okayama, Japan. ueda-y@kchnet.or.jp
Mizutani C
Nannya Y
Kurokawa M
Kobayashi S
Takeuchi J
Tamura H
Ogata K
Dan K
Shibayama H
Kanakura Y
Niimi K
Sasaki K
Watanabe M
Emi N
Teramura M
Motoji T
Kida M
Usuki K
Takada S
Sakura T
Ito Y
Ohyashiki K
Ogawa H
Suzuki T
Ozawa K
Imai K
Kasai M
Hata T
Miyazaki Y
Morita Y
Kanamaru A
Matsuda A
Tohyama K
Koga D
Tamaki H
Mitani K
Naoe T
Sugiyama H
Takaku F
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2013 Jul; Vol. 54 (7), pp. 1450-8. Date of Electronic Publication: 2012 Nov 26.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression*
RNA, Messenger*
Myelodysplastic Syndromes/*genetics
WT1 Proteins/*genetics
Adult ; Aged ; Aged, 80 and over ; Bone Marrow Cells/metabolism ; Disease Progression ; Female ; Humans ; Karyotyping ; Leukocytes/metabolism ; Male ; Middle Aged ; Myelodysplastic Syndromes/diagnosis ; Myelodysplastic Syndromes/metabolism ; Prognosis ; WT1 Proteins/metabolism ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Correlation between the low marrow blast cutpoint and WHO classification for myelodysplastic syndromes.
Autorzy:
Matsuda A
Germing U
Miyazaki Y
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2013 Jan; Vol. 90 (1), pp. 79-80. Date of Electronic Publication: 2012 Nov 22.
Typ publikacji:
Letter
MeSH Terms:
Myelodysplastic Syndromes/*diagnosis
Bone Marrow/pathology ; Humans ; Myelodysplastic Syndromes/classification ; Prognosis
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification.
Autorzy:
Matsuda A; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Saitama Medical University, Iruma-gun, Saitama, Japan. />Germing U
Jinnai I
Iwanaga M
Misumi M
Kuendgen A
Strupp C
Miyazaki Y
Tsushima H
Sakai M
Bessho M
Gattermann N
Aul C
Tomonaga M
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2007 Apr; Vol. 21 (4), pp. 678-86. Date of Electronic Publication: 2007 Feb 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anemia/*epidemiology
Megakaryocytes/*pathology
Myelodysplastic Syndromes/*classification
Myelodysplastic Syndromes/*pathology
Adult ; Chromosome Mapping ; Female ; Germany ; Humans ; Japan ; Male ; Middle Aged ; Myelodysplastic Syndromes/genetics ; Myelodysplastic Syndromes/mortality ; Prognosis ; Survival Analysis ; Survivors ; World Health Organization
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Colony-forming unit-megakaryocyte (CFR-meg) numbers and serum thrombopoietin concentrations in thrombocytopenic disorders: an inverse correlation in myelodysplastic syndromes.
Autorzy:
Wang W; Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University School of Medicine, Japan.
Matsuo T
Yoshida S
Mori H
Miyazaki Y
Kuriyama K
Tomonaga M
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2000 Oct; Vol. 14 (10), pp. 1751-6.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cells*
Megakaryocytes/*cytology
Myelodysplastic Syndromes/*blood
Thrombocytopenia/*blood
Thrombopoietin/*blood
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Platelet Count
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 40

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies